Search research articles
Contact Us
Filters
Showing results (81-90 of 211) with videos related to
Page
of 22
Sort By:
Expert Opinion on Emerging Drugs
|
November 21, 2012
Emerging human papillomavirus vaccines
Barbara Ma, Bharat Maraj, Nam Phuong Tran, et al.
Gynecologic Oncology
|
April 16, 2008
Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
Robert Morris, Ronald D Alvarez, Stephen Andrews, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
April 19, 2008
Lipoxygenase pathway receptor expression in ovarian cancer
Rodney P Rocconi, Tyler O Kirby, Robert S Seitz, et al.
Gynecologic Oncology
|
August 16, 2014
SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm
Thomas J Herzog, Ronald D Alvarez, Angeles Secord, et al.
Journal of Ovarian Research
|
October 28, 2016
IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
Eric D Thomas, Selene Meza-Perez, Kerri S Bevis, et al.
Gynecologic Oncology
|
September 10, 2002
Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment
David Heddens, David S Alberts, Edward V Hannigan, et al.
Cancer
|
October 15, 2010
A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia
Chandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
The Journal of Reproductive Medicine
|
March 17, 2004
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series
Charles A Leath, J Michael Straughn, Michael G Conner, et al.
Archives of Gynecology and Obstetrics
|
April 13, 2010
Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer
Christopher S Bryant, Sanjeev Kumar, Whitney Spannuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group
Mahesh A Varia, Frederick B Stehman, Brian N Bundy, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 211) with videos related to
Sort By:
Page
of 22
Expert Opinion on Emerging Drugs
|
November 21, 2012
Emerging human papillomavirus vaccines
Barbara Ma, Bharat Maraj, Nam Phuong Tran, et al.
Gynecologic Oncology
|
April 16, 2008
Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
Robert Morris, Ronald D Alvarez, Stephen Andrews, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
April 19, 2008
Lipoxygenase pathway receptor expression in ovarian cancer
Rodney P Rocconi, Tyler O Kirby, Robert S Seitz, et al.
Gynecologic Oncology
|
August 16, 2014
SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm
Thomas J Herzog, Ronald D Alvarez, Angeles Secord, et al.
Journal of Ovarian Research
|
October 28, 2016
IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
Eric D Thomas, Selene Meza-Perez, Kerri S Bevis, et al.
Gynecologic Oncology
|
September 10, 2002
Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment
David Heddens, David S Alberts, Edward V Hannigan, et al.
Cancer
|
October 15, 2010
A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia
Chandrika J Piyathilake, Maurizio Macaluso, Ronald D Alvarez, et al.
The Journal of Reproductive Medicine
|
March 17, 2004
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series
Charles A Leath, J Michael Straughn, Michael G Conner, et al.
Archives of Gynecology and Obstetrics
|
April 13, 2010
Feasibility of extension of platinum-free interval with weekly bolus topotecan and subsequent platinum retreatment outcomes in recurrent ovarian cancer
Christopher S Bryant, Sanjeev Kumar, Whitney Spannuth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2003
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group
Mahesh A Varia, Frederick B Stehman, Brian N Bundy, et al.
Page
of 22